REG - Hikma Pharmaceutical - Director/PDMR Shareholding
24/04/2023 16:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230424:nRSX2716Xa&default-theme=true
RNS Number : 2716X Hikma Pharmaceuticals Plc 24 April 2023
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 24 April 2023: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons
Discharging Managerial Responsibility ("PDMR") have received shares as a
result of the vesting of their conditional share awards which were granted on
25 February 2021 under the 2014 Executive Incentive Plan ("EIP") Element B and
27 February 2020 under the EIP Element C.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman and Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 34,827
d) Aggregated information
- Volume
- Price 34,827
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 27,057
d) Aggregated information
- Volume
- Price 27,057
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 24,319
d) Aggregated information
- Volume
- Price 24,319
£0.00
Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 18,831
d) Aggregated information
- Volume
- Price 18,831
£0.00
Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Riad Mishlawi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 20,285
d) Aggregated information
- Volume
- Price 20,285
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 22,437
d) Aggregated information
- Volume
- Price 22,437
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Majda Labadi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 11,205
d) Aggregated information
- Volume
- Price 11,205
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 10,690
d) Aggregated information
- Volume
- Price 10,690
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Bassam Kanaan
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 17,307
d) Aggregated information
- Volume
- Price 17,307
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 17,007
d) Aggregated information
- Volume
- Price 17,007
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 17,390
d) Aggregated information
- Volume
- Price 17,390
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 17,180
d) Aggregated information
- Volume
- Price 17,180
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Brian Hoffmann
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. 4,436 Shares were sold to cover tax and
the remainder were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 7,683
Price(s): £18.065
Volume(s): 4,436
d) Aggregated information
- Volume
- Price 12,119
£18.065
- Total £80,136.34
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C. 4,378 Shares were sold to cover tax and
the remainder were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 7,584
Price(s): £18.065
Volume(s): 4,378
d) Aggregated information
- Volume
- Price 11,962
£18.065
- Total £79,088.57
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Susan Ringdal
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. 3,990 Shares were sold to cover tax
and the remainder were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 4,823
Price(s): £18.065
Volume(s): 3,990
d) Aggregated information
- Volume
- Price 8,813
£18.065
- Total £72,079.35
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element C 4,017 Shares were sold to cover tax and
the remainder were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 4,857
Price(s): £18.065
Volume(s): 4,017
d) Aggregated information
- Volume
- Price 8,874
£18.065
- Total £72,567.105
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards on
17 April 2023 under the EIP Element B. All Shares were retained.
c) Price(s) and volume(s) Price(s): £nil
Volume(s): 7,867
d) Aggregated information
- Volume
- Price 7,867
£0.00
- Total £0.00
e) Date of the transaction 17 April 2023
f) Place of the transaction London Stock Exchange (XLON)
Hussein Arkhagha
Chief Counsel and Company Secretary
+44 (0) 20 7399 2760
24 April 2023
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBUGDSXBDDGXSRecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement